Nico Riedel

Nico Riedel

Auto-generated profile, based on publicly available information

Nico Riedel

QUEST Center for Transforming Biomedical Research, Berlin Institute of Health, Berlin, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in PLOS Biology
Verified
Journal Article
Open access
PDF file
SSStylianos Serghiou
Stylianos Serghiou
DCDespina G. Contopoulos-Ioannidis
Despina G. Contopoulos-Ioannidis
KBKevin W. Boyack
Kevin W. Boyack
NRNico Riedel
Nico Riedel
JWJoshua D. Wallach
Joshua D. Wallach
JIJohn P. A. Ioannidis
John P. A. Ioannidis
Recent concerns about the reproducibility of science have led to several calls for more open and transparent research practices and for the monitoring of potential improvements over time. However, with tens of thousands of new biomedical articles published per week, manually mapping and monitoring changes in transparency is unrealistic. We present an open-source, automated approach to identify 5 indicators of transparency (data sharing, code sharing, conflicts of interest disclosures, funding disclosures, and protocol registration) and apply it across the entire open access biomedical literature of 2.75 million articles on PubMed Central (PMC). Our results indicate remarkable improvements in some (e.g., conflict of interest [COI] disclosures and funding disclosures), but not other (e.g., protocol registration and code sharing) areas of transparency over time, and map transparency across fields of science, countries, journals, and publishers. This work has enabled the creation of a large, integrated, and openly available database to expedite further efforts to monitor, understand, and promote transparency and reproducibility in science.

23 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JMJie Mei
Jie Mei
NRNico Riedel
Nico Riedel
UGUlrike Grittner
Ulrike Grittner
MEMatthias Endres
Matthias Endres
SBStefanie Banneke
Stefanie Banneke
JEJulius Valentin Emmrich
Julius Valentin Emmrich
Body temperature is a valuable parameter in determining the wellbeing of laboratory animals. However, using body temperature to refine humane endpoints during acute illness generally lacks comprehensiveness and exposes to inter-observer bias. Here we compared two methods to assess body temperature in mice, namely implanted radio frequency identification (RFID) temperature transponders (method 1) to non-contact infrared thermometry (method 2) in 435 mice for up to 7 days during normothermia and lipopolysaccharide (LPS) endotoxin-induced hypothermia. There was excellent agreement between core and surface temperature as determined by method 1 and 2, respectively, whereas the intra- and inter-subject variation was higher for method 2. Nevertheless, using machine learning algorithms to determine temperature-based endpoints both methods had excellent accuracy in predicting death as an outcome event. Therefore, less expensive and cumbersome non-contact infrared thermometry can serve as a reliable alternative for implantable transponder-based systems for hypothermic responses, although requiring standardization between experimenters.

11 January 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TWTracey Weissgerber
Tracey Weissgerber
NRNico Riedel
Nico Riedel
HKHalil Kilicoglu
Halil Kilicoglu
CLCyril Labbé
Cyril Labbé
PEPeter Eckmann
Peter Eckmann
ABAnita Bandrowski
Anita Bandrowski

1 November 2019 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
SWSusanne Wieschowski
Susanne Wieschowski
NRNico Riedel
Nico Riedel
KWKatharina Wollmann
Katharina Wollmann
HKHannes Kahrass
Hannes Kahrass
SMStephanie Müller-Ohlraun
Stephanie Müller-Ohlraun
DSDaniel Strech
Daniel Strech

3 January 2020 in Data Science Journal
Verified
Journal Article
Open access
PDF file
NRNico Riedel
Nico Riedel
MKMiriam Kip
Miriam Kip
EBEvgeny Bobrov
Evgeny Bobrov
Open research data are increasingly recognized as a quality indicator and an important resource to increase transparency, robustness and collaboration in science. However, no standardized way of reporting Open Data in publications exists, making it difficult to find shared datasets and assess the prevalence of Open Data in an automated fashion. We developed ODDPub (Open Data Detection in Publications), a text-mining algorithm that screens biomedical publications and detects cases of Open Data. Using English-language original research publications from a single biomedical research institution (n = 8689) and randomly selected from PubMed (n = 1500) we iteratively developed a set of derived keyword categories. ODDPub can detect data sharing through field-specific repositories, general-purpose repositories or the supplement. Additionally, it can detect shared analysis code (Open Code). To validate ODDPub, we manually screened 792 publications randomly selected from PubMed. On this validation dataset, our algorithm detected Open Data publications with a sensitivity of 0.73 and specificity of 0.97. Open Data was detected for 11.5% (n = 91) of publications. Open Code was detected for 1.4% (n = 11) of publications with a sensitivity of 0.73 and specificity of 1.00. We compared our results to the linked datasets found in the databases PubMed and Web of Science. Our algorithm can automatically screen large numbers of publications for Open Data. It can thus be used to assess Open Data sharing rates on the level of subject areas, journals, or institutions. It can also identify individual Open Data publications in a larger publication corpus. ODDPub is published as an R package on GitHub.

1 April 2022 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
NRNico Riedel
Nico Riedel
SWSusanne Wieschowski
Susanne Wieschowski
TBTill Bruckner
Till Bruckner
MHMartin R. Holst
Martin R. Holst
HKHannes Kahrass
Hannes Kahrass
DSDaniel Strech
Daniel Strech
Timely publication of clinical trial results is central for evidence-based medicine. In this follow-up study we benchmark the performance of German university medical centers (UMCs) regarding timely dissemination of clinical trial results in recent years. Following the same search and tracking methods used in our previous study for the years 2009 - 2013, we identified trials led by German UMCs completed between 2014 and 2017 and tracked results dissemination for the identified trials. We identified 1,658 trials in the 2014 -2017 cohort. Of these trials, 43% published results as either journal publication or summary results within 24 months after completion date, which is an improvement of 3.8% percentage points compared to the previous study. At the UMC level, the proportion published after 24 months ranged from 14% to 71%. Five years after completion, 30% of the trials still remained unpublished. Despite minor improvements compared to the previously investigated cohort, the proportion of timely reported trials led by German UMCs remains low. German UMCs should take further steps to improve the proportion of timely reported trials.